Lin Li

Tinengotinib (TT-00420), a Novel Spectrum-Selective Small-Molecule Kinase Inhibitor, Is Highly Active Against Triple-Negative Breast Cancer

Qi Yu, Shumao Ni, Laura Sourd, 2022, Molecular cancer therapeutics.